-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Conduit Pharmaceuticals Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate for Q4 2023.
- Conduit Pharmaceuticals Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $813K.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)